1. Home
  2. MDXH vs NB Comparison

MDXH vs NB Comparison

Compare MDXH & NB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • NB
  • Stock Information
  • Founded
  • MDXH 2003
  • NB 1987
  • Country
  • MDXH Belgium
  • NB United States
  • Employees
  • MDXH N/A
  • NB N/A
  • Industry
  • MDXH
  • NB Metal Mining
  • Sector
  • MDXH
  • NB Basic Materials
  • Exchange
  • MDXH Nasdaq
  • NB Nasdaq
  • Market Cap
  • MDXH 78.3M
  • NB 70.3M
  • IPO Year
  • MDXH 2021
  • NB N/A
  • Fundamental
  • Price
  • MDXH $2.53
  • NB $1.73
  • Analyst Decision
  • MDXH Strong Buy
  • NB Strong Buy
  • Analyst Count
  • MDXH 2
  • NB 1
  • Target Price
  • MDXH $7.50
  • NB $8.50
  • AVG Volume (30 Days)
  • MDXH 44.6K
  • NB 72.7K
  • Earning Date
  • MDXH 11-06-2024
  • NB 09-13-2024
  • Dividend Yield
  • MDXH N/A
  • NB N/A
  • EPS Growth
  • MDXH N/A
  • NB N/A
  • EPS
  • MDXH N/A
  • NB N/A
  • Revenue
  • MDXH $80,741,000.00
  • NB N/A
  • Revenue This Year
  • MDXH $24.45
  • NB N/A
  • Revenue Next Year
  • MDXH $15.22
  • NB N/A
  • P/E Ratio
  • MDXH N/A
  • NB N/A
  • Revenue Growth
  • MDXH 45.51
  • NB N/A
  • 52 Week Low
  • MDXH $0.35
  • NB $1.62
  • 52 Week High
  • MDXH $4.64
  • NB $5.20
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 37.08
  • NB 44.75
  • Support Level
  • MDXH $2.84
  • NB $1.65
  • Resistance Level
  • MDXH $2.74
  • NB $1.96
  • Average True Range (ATR)
  • MDXH 0.12
  • NB 0.14
  • MACD
  • MDXH -0.05
  • NB -0.01
  • Stochastic Oscillator
  • MDXH 0.00
  • NB 18.42

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.

About NB NioCorp Developments Ltd.

NioCorp Developments Ltd is a pure play critical minerals project in Nebraska that plans to produce niobium, scandium, titanium, and magnetic rare earths. The Elk Creek Project is the highest-grade Niobium project under development in North America and is the second largest indicated or rare earth Mineral Resource in the United States. All of NioCorp's planned products are designed as critical by the United States Government. All are vital to clean technologies and the global energy transition.

Share on Social Networks: